An autoimmune or an inflammatory process in patients with schizophrenia, schizoaffective disorder, and in their biological relatives

Schizophrenia Research

Volumn 84, Issue 1, 2006, Pages 180-182

  Nunes, Sandra O V ^a   Matsuo, Tiemi ^a   Kaminami, Mari S ^a   Watanabe, Maria Angélica E ^a   Reiche, Edna Maria V ^a   Itano, Eiko N ^a  

^a Department of Psychiatry Londrina State University ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; INTERLEUKIN 6; NEUROLEPTIC AGENT;

ADULT; ANTIBODY PRODUCTION; AUTOIMMUNITY; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; HOSPITALIZATION; HUMAN; INFLAMMATION; LETTER; MENTAL DISEASE; MOOD DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

AUTOANTIBODIES; BRAIN; HIPPOCAMPUS; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-6; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 33646504630     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.02.003     Document Type: Letter

References (8)

1. Del Bem C., Vilela J., Crippa J., Labate C., and Zuardi A. Confiabilidade da "entrevistaclínica estruturada para o D.S.M.-IV". Rev. Bras. Psiquiatr. 23 (2001) 156-159 (Versão clínica traduzida para o português)
2. Lin A., Kenis G., Bignotti S., Tura G., De Jong R., Bosmans E., Pioli R., Altamura C., Scharpé S., and Maes M. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr. Res. 32 (1998) 9-15
3. Maes M., Chiavetto L., Bignotti S., Tura G., Pioli R., Boin F., et al. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur. Neuropsychopharmacol. 10 (2000) 119-124
4. Maes M., Chiavetto L., Bignotti S., Tura G., Pioli R., Boin F., et al. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr. Res. 54 (2002) 281-291
5. Müller N., Riedel M., Ackenheil M., and Schwarz M. Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation. World J. Biol. Psychiatr. 1 (2000) 173-179
6. Nunes, S.O.V., Borelli, S., Matsuo T., Watanabe, M.A, Itano, E.N., 2005. The association of the HLA in patients with schizophrenia, schizoaffective disorder, and their biological relatives. Schizophrenia Research;{s.l.}.76: (.2/3), 195-198
7. Rothermundt M., Arolt V., and Bayer T. Review of immunological and immunopathological findings in schizophrenia. Brain Behav. Immunol. 15 (2001) 319-339
8. Schwarz M., Müller N., Riedel M., and Ackenheil M. The Th-2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med. Hypotheses 56 (2001) 483-486